Electromed, Inc. (ELMD) stock
ELMDNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends June 30
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 21/3028% below fair value
$23.10−1.22 (-5.02%)
Close on Nov 16, 2026Market cap $193.26MP/E 17.8Yield –
Electromed r&d expenses
Research and development expenses are spending on new products and technology.
Electromed's R&D Expenses for the twelve months ending Jun 30, 2026 was $1.31M, up 31.9% year over year. For fiscal 2026 it was $1.31M, up 31.9% from the year before. Over ten years it grew 13.2% a year on average. The highest annual figure on record is $1.72M in fiscal 2021.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | $1.31M | +31.9% |
| FY2025 | Jun 30, 2025 | $996.00K | +51.8% |
| FY2024 | Jun 30, 2024 | $656.00K | -28.4% |
| FY2023 | Jun 30, 2023 | $916.00K | -32.4% |
| FY2022 | Jun 30, 2022 | $1.36M | -21.3% |
| FY2021 | Jun 30, 2021 | $1.72M | +64.0% |
| FY2020 | Jun 30, 2020 | $1.05M | +80.0% |
| FY2019 | Jun 30, 2019 | $583.31K | +132.0% |
| FY2018 | Jun 30, 2018 | $251.44K | -57.9% |
| FY2017 | Jun 30, 2017 | $596.88K | +56.9% |
| FY2016 | Jun 30, 2016 | $380.39K | +20.5% |
| FY2015 | Jun 30, 2015 | $315.65K | -32.3% |
| FY2014 | Jun 30, 2014 | $466.06K | -22.8% |
| FY2013 | Jun 30, 2013 | $603.38K | -34.5% |
| FY2012 | Jun 30, 2012 | $920.77K | -10.9% |
| FY2011 | Jun 30, 2011 | $1.03M | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | $328.00K | +8.6% |
| Q3 FY2026CQ1 2026 | Mar 31, 2026 | $361.00K | +30.3% |
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | $384.00K | +53.0% |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | $241.00K | +45.2% |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | $302.00K | +71.6% |
| Q3 FY2025CQ1 2025 | Mar 31, 2025 | $277.00K | +65.9% |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | $251.00K | +134.6% |
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | $166.00K | -19.4% |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | $176.00K | -40.9% |
| Q3 FY2024CQ1 2024 | Mar 31, 2024 | $167.00K | +0.6% |
| Q2 FY2024CQ4 2023 | Dec 31, 2023 | $107.00K | -30.5% |
| Q1 FY2024CQ3 2023 | Sep 30, 2023 | $206.00K | -30.9% |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | $298.00K | -5.4% |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | $166.00K | -50.6% |
| Q2 FY2023CQ4 2022 | Dec 31, 2022 | $154.00K | -53.2% |
| Q1 FY2023CQ3 2022 | Sep 30, 2022 | $298.00K | -20.7% |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | $315.00K | -3.4% |
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | $336.00K | -17.4% |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | $329.00K | -35.1% |
| Q1 FY2022CQ3 2021 | Sep 30, 2021 | $376.00K | -21.8% |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | $326.00K | -21.6% |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | $407.00K | +3.8% |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | $507.00K | +253.4% |
| Q1 FY2021CQ3 2020 | Sep 30, 2020 | $481.00K | +386.2% |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | $415.62K | +290.2% |
| Q3 FY2020CQ1 2020 | Mar 31, 2020 | $391.96K | +129.5% |
| Q2 FY2020CQ4 2019 | Dec 31, 2019 | $143.48K | -39.7% |
| Q1 FY2020CQ3 2019 | Sep 30, 2019 | $98.94K | +45.1% |
| Q4 FY2019CQ2 2019 | Jun 30, 2019 | $106.53K | +31.0% |
| Q3 FY2019CQ1 2019 | Mar 31, 2019 | $170.76K | +300.2% |
| Q2 FY2019CQ4 2018 | Dec 31, 2018 | $237.84K | +318.8% |
| Q1 FY2019CQ3 2018 | Sep 30, 2018 | $68.19K | -3.5% |
| Q4 FY2018CQ2 2018 | Jun 30, 2018 | $81.32K | +25.8% |
| Q3 FY2018CQ1 2018 | Mar 31, 2018 | $42.67K | -47.1% |
| Q2 FY2018CQ4 2017 | Dec 31, 2017 | $56.79K | -43.7% |
| Q1 FY2018CQ3 2017 | Sep 30, 2017 | $70.66K | -79.9% |
| Q4 FY2017CQ2 2017 | Jun 30, 2017 | $64.62K | – |
| Q3 FY2017CQ1 2017 | Mar 31, 2017 | $80.61K | – |
| Q2 FY2017CQ4 2016 | Dec 31, 2016 | $100.80K | – |
| Q1 FY2017CQ3 2016 | Sep 30, 2016 | $350.84K | – |
See a number that looks wrong?